Sunesis Pharmaceuticals Inc
Sunesis Pharmaceuticals Announces Presentation of Updated Results from the VALOR Trial Examining Overall Survival in Patients Age 60 Years and Older with Relapsed/Refractory AML at the ASH Annual Meeting
Format
JPEG
Source
Sunesis Pharmaceuticals, Inc.